South San Francisco, CA June 30, 2018 Press Release Genentech’s TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy –IMpower133 is the first Phase III study with an immunotherapy-based…
Tag: Cancer
Cancer Research Institute Celebrates Sixth Annual Cancer Immunotherapy Month™ in June
South San Francisco, CA June 21, 2018 by Cancer Research Institute 30 days of education and awareness programming for patients, caregivers, and the public about cancer immunotherapy and clinical trials Join in #WearWhite Day on Friday, June 15, our signature…
FDA Approves Rituxan Hycela (Rituximab and Hyaluronidase Human) for Subcutaneous Injection in Certain Blood Cancers
South San Francisco, CA June 23, 2017 Genentech Press Release Treatment can be administered in five to seven minutes, compared to 1.5 hours or more for intravenous Rituxan — SOUTH SAN FRANCISCO, CA — 2017-06-22 00:00:00 Genentech, a member…
SFSU Alpha Kappa Psi Presents HeartBeats Benefit Concert With GIRAFFAGE March 3rd at the Annex
South San Francisco, CA January 20, 2017 Erick Ostorga, SFSU Alpha Kappa Psi, contributed to this article Erick Ostorga, alumni of El Camino High School Class of 2015, continues his educational career at San Francisco State University where he is part of an…
San Bruno, SSF, Daly City Team Up For 2017 Relay For Life
South San Francisco, CA December 31, 2016 Submitted by Robert Riechel, SB Patch The American Cancer Society and Relay For Life Advise: MISSION MOMENT! The American Cancer Society has teamed up with solo artist and Black Eyed Peas member,…
Son Reports Deplorable Conditions at Local Hospital as Father Battles Cancer
South San Francisco, CA August 12, 2016 Submitted by Robert Barrett I went to visit my father today at Kaiser SSF who is in a life struggle with cancer. And after a quick room inspection, I found some…
Phase III Study of Genentech’s Alecensa® (alectinib) Showed Superior Efficacy Versus Crizotinib in Japanese People with a Specific Type of Lung Cancer
South San Francisco, CA May 18, 2016 Genentech Press Release First investigational head-to-head study of Alecensa versus crizotinib in people with advanced ALK-positive non-small cell lung cancer (NSCLC) SOUTH SAN FRANCISCO, CA — 2016-05-18 00:00:00 Genentech, a member of…
SSF Neighbor Lynn Brunetti Ellison: A Story of Inspiration and Love
South San Francisco, Ca February 14, 2016 Valentines Day Every now and then our attention is pulled to an exceptional person who has made a tremendous difference in so many lives and Lynn…
FDA Approves Genentech Drug for Advanced Melanoma
South San Francisco, CA November 10, 2015 Genentech Press Release FDA Approves Genentech’s Cotellic™ (Cobimetinib) in Combination With Zelboraf® (Vemurafenib) in Advanced Melanoma FDA approval underscores the important role of targeted medicines to help people with BRAF…
SSF Firefighter Family Needs Our Help As Cancer Strikes Again
South San Francisco, CA July 6, 2015 South San Francisco Fire Captain Paule Medeiros has always been at the forefront in helping our City; whether that be working to get grants for our Fire Department needs or taking…